Streetbeat News

Stock Prices

CNYA

FLCH

FXI

GXC

KWEB

MCHI

PGJ

Chinese stocks have surged, driven by economic recovery signs and a rally in the SSE Composite Index, despite concerns over premature investor optimism and downward earnings revisions. ETFs like KWEB, MCHI, FXI, GXC, CNYA, PGJ, and FLCH offer exposure to China's market, each with unique strategies and year-to-date returns.

Portfolio Pulse from Piero Cingari

May 08, 2024 | 4:04 pm

EMR

Emerson Electric's stock is trading higher following the announcement of better-than-expected Q2 earnings and an upward revision of its FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 4:03 pm

ASML

Recent options activity for ASML Holding (NASDAQ:ASML) shows a balanced mix of bullish and bearish sentiment among investors, with significant trades ranging between $410.0 to $1050.0 strike prices. The volume and open interest analysis suggests a keen interest in ASML's options within this price window. ASML, a leader in photolithography systems for semiconductor manufacturing, has its stock currently trading at $906.92, with a neutral RSI and an upcoming earnings report in 70 days. An analyst from Bernstein maintains an Outperform rating with a target price of $1052.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 4:01 pm

Noble Corp (NYSE:NE) has been the subject of diverse analyst evaluations over the past three months, with ratings ranging from bullish to bearish. The average 12-month price target among analysts is $52.8, down from $54.40, indicating a 2.94% decrease. Analyst actions include both downgrades and upgrades, reflecting changing market dynamics and company performance. Noble Corp's financials show a revenue decline of -0.92% over the last quarter, but it maintains a strong net margin of 14.99% and an above-average ROE of 2.44%. The company's debt-to-equity ratio is low at 0.15, suggesting a healthy balance between debt and equity.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 4:01 pm

AMGN

Whales have shown a bearish stance on Amgen (NASDAQ:AMGN), with 58% of observed options trades being bearish. The trades indicate a target price range of $240.0 to $310.0 for AMGN over the last 3 months. The largest trades include both puts and calls, with a notable bearish sentiment. Amgen, a leader in biotechnology-based therapeutics, is currently trading at $303.07, up by 0.92%, but may be overbought according to RSI readings. Its next earnings release is anticipated in 85 days.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 4:01 pm

JPM

Financial giants have shown a bullish sentiment on JPMorgan Chase (JPM) through options trading, with a mix of bullish and bearish trades observed. The trading activity suggests a target price range of $160 to $200 for JPM over the next three months. Analysis of the largest trades includes both puts and calls with varying sentiments and strike prices. JPMorgan Chase, a major financial institution with nearly $3.9 trillion in assets, has seen its stock price increase by 0.49% to $192.69. Analysts have given JPM an average target price of $212.4, with ratings ranging from Market Perform to Overweight.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 4:01 pm

AMD

FTXL

INTC

NVDA

QCOM

SHOC

Intel Corp (NASDAQ:INTC) anticipates Q2 2024 revenue to be below the midpoint of its $12.5 billion to $13.5 billion guidance, affected by the U.S. ban on exports to Huawei. This follows the U.S. Department of Commerce revoking licenses for consumer-related exports to China, impacting both Intel and Qualcomm Inc (NASDAQ:QCOM). Despite this, Intel expects year-over-year growth in 2024 revenue and EPS. The ban, part of broader U.S. efforts to limit China's access to semiconductor technology, also affects other chipmakers like AMD (NASDAQ:AMD) and Nvidia Corp (NASDAQ:NVDA). Intel's stock, along with others, has declined, with INTC down over 3% in the last 12 months. Investors can access Intel stock through ETFs like First Trust Nasdaq Semiconductor ETF (NASDAQ:FTXL) and Strive U.S. Semiconductor ETF (NYSE:SHOC).

Portfolio Pulse from Shivani Kumaresan

May 08, 2024 | 4:01 pm

Healthcare Realty Trust (NYSE:HR) has been analyzed by 5 analysts, showing a shift towards a more cautious stance with 4 indifferent ratings recently. The average 12-month price target is now $15.6, marking a 13.33% decrease from previous targets. Financial indicators reveal challenges for HR, including a -2.25% revenue decline, below-average net margin, and ROE, but a healthier debt-to-equity ratio compared to peers. The company focuses on owning, leasing, and managing healthcare properties, with M&A as part of its growth strategy.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 4:01 pm

VERI

Veritone shares surged following the announcement of better-than-expected Q1 earnings and the issuance of strong future guidance.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 3:54 pm

RDFN

Stephens & Co. analyst John Campbell upgraded Redfin (NASDAQ:RDFN) from Equal-Weight to Overweight and increased the price target from $8 to $9.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 3:52 pm